The research with psychedelic drugs can change our understanding of the human mind. Watch our video report from the International Interdisciplinary Conference on Psychedelic Research! Watch some of the key presentations too!

Roland R. Griffiths: Overview of the Johns Hopkins Psilocybin Research Project

Roland R. Griffiths, PhD, is Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine.

Rick Doblin: Regulatory challenges involved in developing psychedelic- assisted psychotherapy through the FDA/EMA process.

Rick Doblin, Ph.D., is the founder (in 1986) and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS).

George Goldsmith: Accelerating patient access to psychedelic-assisted psychotherapy

George Goldsmith is a co-founder and director of COMPASS – a non-profit medical re- search organisation dedicated to accelerating access to evidence-led innovation in mental health and wellbeing.

Alicia Danforth: Exploring MDMA-assisted therapy as a new pathway to social adaptability for autistic adults

Alicia Danforth, PhD is a psychologist and co-investigator for a random- ized, double-blinded, placebo-controlled study on MDMA-assisted therapy for social anxiety in autistic adults.

Marcela Ot’alora: Using MDMA for trauma integration

Marcela has dedicated her professional life to the treatment and research of trauma, specifically PTSD, first through art and later through the use of MDMA-assisted Psychotherapy.

Tarik Najeddine: Novel Psychedelic Substances: A Grave Threat to the Psychedelic Renaissance

Tarik Najeddine obtained his Masters degree in clinical psychology at Columbia Uni- versity, and is now an independent researcher, blogger & harm reduction coordinator based in New York City.

Levente Móró: Crisis Intervention at Psychedelic Festivals

Levente Móró is a PhD candidate in the Centre for Cognitive Neuroscience at the Uni- versity of Turku in Finland.

Jeffrey Guss: The NYU School of Medicine Study on Psilocybin-Assisted Therapy for treatment of Existential Distress in Cancer Patients: History, Study Structure, Therapist Training, Outcome Data.

Jeffrey Guss, MD is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy and the treatment of substance use disorders.

Videos produced by István Gábor Takács and Peter Sarosi